ZNF555
gene geneOn this page
Also known as MGC26707
Summary
ZNF555 (zinc finger protein 555, HGNC:28382) is a protein-coding gene on chromosome 19p13.3, encoding Zinc finger protein 555 (Q8NEP9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 148254 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_152791
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28382 |
| Approved symbol | ZNF555 |
| Name | zinc finger protein 555 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC26707 |
| Ensembl gene | ENSG00000186300 |
| Ensembl biotype | protein_coding |
| Entrez | 148254 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
ENST00000334241, ENST00000585966, ENST00000591539, ENST00000905416, ENST00000940323
RefSeq mRNA: 2 — MANE Select: NM_152791
NM_001172775, NM_152791
CCDS: CCDS12096, CCDS59329
Canonical transcript exons
ENST00000334241 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001337612 | 2851468 | 2851651 |
| ENSE00001337615 | 2852380 | 2860471 |
| ENSE00001337616 | 2841475 | 2841575 |
| ENSE00003600807 | 2850587 | 2850713 |
Expression profiles
Bgee: expression breadth ubiquitous, 234 present calls, max score 92.98.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.0725 / max 81.5612, expressed in 1645 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173128 | 5.0752 | 1602 |
| 173129 | 0.9973 | 616 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| amniotic fluid | UBERON:0000173 | 92.98 | gold quality |
| secondary oocyte | CL:0000655 | 92.56 | gold quality |
| oocyte | CL:0000023 | 92.08 | gold quality |
| sperm | CL:0000019 | 87.85 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.91 | gold quality |
| buccal mucosa cell | CL:0002336 | 82.15 | gold quality |
| cortical plate | UBERON:0005343 | 80.00 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.46 | gold quality |
| cartilage tissue | UBERON:0002418 | 78.38 | gold quality |
| ventricular zone | UBERON:0003053 | 77.40 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 77.18 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.01 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.17 | gold quality |
| corpus callosum | UBERON:0002336 | 74.13 | gold quality |
| stromal cell of endometrium | CL:0002255 | 73.92 | gold quality |
| adrenal tissue | UBERON:0018303 | 72.80 | gold quality |
| calcaneal tendon | UBERON:0003701 | 72.77 | gold quality |
| endometrium | UBERON:0001295 | 72.61 | gold quality |
| medial globus pallidus | UBERON:0002477 | 72.25 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 72.20 | gold quality |
| leukocyte | CL:0000738 | 71.77 | gold quality |
| monocyte | CL:0000576 | 71.59 | gold quality |
| left ovary | UBERON:0002119 | 71.35 | gold quality |
| ovary | UBERON:0000992 | 71.27 | gold quality |
| heart left ventricle | UBERON:0002084 | 70.93 | gold quality |
| cardiac ventricle | UBERON:0002082 | 70.87 | gold quality |
| globus pallidus | UBERON:0001875 | 70.72 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 70.62 | gold quality |
| uterus | UBERON:0000995 | 70.58 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 70.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
156 targeting ZNF555, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
Literature-anchored findings (GeneRIF, showing 1)
- Identification of ZNF555 as a putative transcriptional factor highly expressed in human primary myoblasts that interacts with the beta-satellite repeats enhancer site and impacts the ANT1 promoter activity in facioscapulohumeral dystrophy myoblasts. (PMID:26184877)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 555 — Q8NEP9 (reviewed: Q8NEP9)
All UniProt accessions (2): Q8NEP9, K7ENK0
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NEP9-1 | 1 | yes |
| Q8NEP9-2 | 2 | |
| Q8NEP9-4 | 3 |
RefSeq proteins (2): NP_001166246, NP_690004* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050752 | C2H2-ZF_domain | Family |
Pfam: PF00096, PF01352, PF13894
UniProt features (25 total): zinc finger region 15, sequence variant 4, splice variant 3, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEP9-F1 | 68.78 | 0.06 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 57 (showing top):
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP, PEDRIOLI_MIR31_TARGETS_UP, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ASH1L_TARGET_GENES, CEBPZ_TARGET_GENES, CREB3L4_TARGET_GENES, LHX9_TARGET_GENES, OVOL3_TARGET_GENES, PHF21A_TARGET_GENES, PRKDC_TARGET_GENES, SALL4_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
368 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF555 | SPATA31E1 | Q6ZUB1 | 505 |
| ZNF555 | MALRD1 | Q5VYJ5 | 422 |
| ZNF555 | CYLC2 | Q14093 | 418 |
| ZNF555 | FANK1 | Q8TC84 | 417 |
| ZNF555 | ZNF474 | Q6S9Z5 | 393 |
| ZNF555 | SPMIP9 | Q96LM6 | 376 |
| ZNF555 | SPATA24 | Q86W54 | 376 |
| ZNF555 | SPATC1 | Q76KD6 | 370 |
| ZNF555 | TRIM28 | Q13263 | 366 |
| ZNF555 | MOSPD1 | Q9UJG1 | 358 |
| ZNF555 | ZC3H6 | P61129 | 357 |
| ZNF555 | CACNA1B | Q00975 | 353 |
| ZNF555 | SPATA3 | Q8NHX4 | 349 |
| ZNF555 | DCUN1D5 | Q9BTE7 | 348 |
| ZNF555 | CBY2 | Q8NA61 | 325 |
IntAct
15 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCNDBP1 | ZNF555 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF555 | CCNDBP1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ZNF555 | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF555 | CEP70 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF555 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP70 | ZNF555 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF555 | HERC1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): ZNF555 (Two-hybrid), ZNF555 (Two-hybrid), KRTAP10-7 (Two-hybrid), FAM73A (Affinity Capture-MS), MTCL1 (Affinity Capture-MS), HERC1 (Affinity Capture-MS), ZNF555 (Affinity Capture-RNA), HERC1 (Affinity Capture-MS), FAM73A (Affinity Capture-MS), MTCL1 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS), ZNF555 (Affinity Capture-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 79 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
660 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:2841573:ATGGT:A | donor_loss | 1.0000 |
| 19:2841574:TGGTG:T | donor_loss | 1.0000 |
| 19:2841575:GGTG:G | donor_loss | 1.0000 |
| 19:2841576:G:C | donor_loss | 1.0000 |
| 19:2850579:T:TA | acceptor_gain | 1.0000 |
| 19:2850582:TTTA:T | acceptor_loss | 1.0000 |
| 19:2850583:TTA:T | acceptor_loss | 1.0000 |
| 19:2850585:A:AG | acceptor_gain | 1.0000 |
| 19:2850585:A:G | acceptor_loss | 1.0000 |
| 19:2850585:AG:A | acceptor_gain | 1.0000 |
| 19:2850586:G:GA | acceptor_gain | 1.0000 |
| 19:2850586:GG:G | acceptor_gain | 1.0000 |
| 19:2850709:AGTAG:A | donor_loss | 1.0000 |
| 19:2850710:GTAG:G | donor_gain | 1.0000 |
| 19:2850711:TAG:T | donor_gain | 1.0000 |
| 19:2850714:G:GG | donor_gain | 1.0000 |
| 19:2850714:GTA:G | donor_loss | 1.0000 |
| 19:2850715:T:G | donor_loss | 1.0000 |
| 19:2851459:T:TA | acceptor_gain | 1.0000 |
| 19:2851466:A:AG | acceptor_gain | 1.0000 |
| 19:2851467:G:GG | acceptor_gain | 1.0000 |
| 19:2852379:GTA:G | acceptor_gain | 1.0000 |
| 19:2841576:G:GG | donor_gain | 0.9900 |
| 19:2850577:ATT:A | acceptor_gain | 0.9900 |
| 19:2850583:TTAGG:T | acceptor_gain | 0.9900 |
| 19:2850584:TAGG:T | acceptor_gain | 0.9900 |
| 19:2850585:A:T | acceptor_gain | 0.9900 |
| 19:2850586:G:C | acceptor_gain | 0.9900 |
| 19:2850586:GGA:G | acceptor_gain | 0.9900 |
| 19:2850586:GGAC:G | acceptor_gain | 0.9900 |
AlphaMissense
4170 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:2852858:T:C | F265L | 0.996 |
| 19:2852860:C:A | F265L | 0.996 |
| 19:2852860:C:G | F265L | 0.996 |
| 19:2852942:T:C | F293L | 0.995 |
| 19:2852944:T:A | F293L | 0.995 |
| 19:2852944:T:G | F293L | 0.995 |
| 19:2853026:T:C | F321L | 0.993 |
| 19:2853028:C:A | F321L | 0.993 |
| 19:2853028:C:G | F321L | 0.993 |
| 19:2852690:T:C | F209L | 0.992 |
| 19:2852692:T:A | F209L | 0.992 |
| 19:2852692:T:G | F209L | 0.992 |
| 19:2853278:T:C | F405L | 0.992 |
| 19:2853280:C:A | F405L | 0.992 |
| 19:2853280:C:G | F405L | 0.992 |
| 19:2852774:T:C | F237L | 0.991 |
| 19:2852776:T:A | F237L | 0.991 |
| 19:2852776:T:G | F237L | 0.991 |
| 19:2853110:T:C | F349L | 0.990 |
| 19:2853112:C:A | F349L | 0.990 |
| 19:2853112:C:G | F349L | 0.990 |
| 19:2853194:T:C | F377L | 0.990 |
| 19:2853196:C:A | F377L | 0.990 |
| 19:2853196:C:G | F377L | 0.990 |
| 19:2853362:T:C | F433L | 0.990 |
| 19:2853364:C:A | F433L | 0.990 |
| 19:2853364:C:G | F433L | 0.990 |
| 19:2852715:G:C | R217P | 0.989 |
| 19:2853446:T:C | F461L | 0.988 |
| 19:2853448:C:A | F461L | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000217973 (19:2849236 C>T), RS1000291602 (19:2849025 G>C), RS1000318270 (19:2843256 T>G), RS1000387075 (19:2856166 T>C), RS1000464593 (19:2844310 C>G,T), RS1000578112 (19:2860944 G>T), RS1000623978 (19:2840275 A>G), RS1000736240 (19:2860638 T>G), RS1000794461 (19:2851511 G>C), RS1000830284 (19:2841775 T>C), RS1001075682 (19:2845777 T>C), RS1001301210 (19:2850323 C>T), RS1001402534 (19:2846073 C>T), RS1001498567 (19:2848832 A>C), RS1001653640 (19:2855211 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003518_101 | Daytime sleep phenotypes | 8.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
30 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression, increases expression | 6 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Cadmium Chloride | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| vanadyl sulfate | decreases expression | 1 |
| diethyl malate | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Azathioprine | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Phthalic Acids | increases methylation | 1 |
| Quercetin | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW63 | HEK293 eGFP-ZNF555 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.